TrialEuropean psychiatry : the journal of the Association of European Psychiatrists2025

Subjective well-being in early-phase schizophrenia patients using long-acting injectable versus oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).

Anna-Theresa Schulze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.